Top

Acta Neurochirurgica

Published in:

01-01-2016 | Clinical Article - Brain Tumors

Long-term outcomes after supratotal resection of diffuse low-grade gliomas: a consecutive series with 11-year follow-up

Author: Hugues Duffau

Published in: Acta Neurochirurgica | Issue 1/2016

Abstract

Background

Total or subtotal surgical resection of WHO grade II glioma (diffuse low-grade glioma, DLGG) can significantly increase survival. Moreover, a supratotal resection, i.e., an extended resection with a margin beyond MR imaging abnormalities, could decrease the risk of malignant transformation. Here, the goal is to analyze the long-term functional and oncological outcomes following supratotal resection for DLGG.

Methods

Sixteen consecutive patients who underwent supratotal resection for a DLGG with a minimum follow-up of 8 years after surgery were included. The resection was continued up to functional cortical and subcortical structures defined by intrasurgical electrical mapping. The extent of resection was evaluated on postoperative FLAIR-weighted MR imaging. Data regarding clinicoradiological features, therapeutic management, and outcomes were analyzed.

Results

Seven men and nine women (mean age, 41.3 years, range, 26–63 years) were included (seizure in 15 cases, one incidental discovery). All patients resumed a normal life after surgery (no neurological deficits, no epilepsy). The volume of postoperative cavity was larger than the preoperative tumor volume in the 16 patients. Neuropathological examination confirmed the diagnosis of WHO grade II glioma in all cases. No adjuvant treatment was administrated after resection. The mean duration of postoperative follow-up was 132 months (range, 97–198 months). There was no relapse in eight cases. Eight patients experienced tumor recurrence, with an average time to relapse of 70.3 months (range, 32–105 months), but without malignant transformation. Five of them have been re-treated, with a reoperation (two cases), chemotherapy (three cases) and radiotherapy (two cases). All patients continue to enjoy a normal life.

Conclusions

This is the first series demonstrating the prolonged impact of supratotal resection on malignant transformation of DLGG. These original data may suggest to remove a margin around the FLAIR-weighted MR imaging abnormalities in a more systematic manner for DLGG not involving eloquent structures.

Ahmadi R, Dictus C, Hartmann C, Zürn O, Edler L, Hartmann M, Combs S, Herold-Mende C, Wirtz CR, Unterberg A (2009) Long-term outcome and survival of surgically treated supratentorial low-grade glioma in adult patients. Acta Neurochir 151:1359–1365PubMedCrossRef

Buckingham SC, Campbell SL, Haas BR, Montana V, Robel S, Ogunrinu T, Sontheimer H (2011) Glutamate release by primary brain tumors induces epileptic activity. Nat Med 17:1969–1974CrossRef

Capelle L, Fontaine D, Mandonnet E, Taillandier L, Golmard JL, Bauchet L, Pallud J, Peruzzi P, Baron MH, Kujas M, Guyotat J, Guillevin R, Frenay M, Taillibert S, Colin P, Rigau V, Vandenbos F, Pinelli C, Duffau H (2013) Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases. J Neurosurg 118:1157–1168PubMedCrossRef

Coello AF, Moritz-Gasser S, Martino J, Martinoni M, Matsuda R, Duffau H (2013) Selection of intraoperative tasks for awake mapping based on relationships between tumor location and functional networks. J Neurosurg 119:1380–1394CrossRef

Cordier D, Gozé C, Schädelin S, Rigau V, Mariani L, Duffau H (2015) A better surgical resectability of WHO grade II gliomas is independent of favorable molecular markers. J Neurooncol 121:185–193PubMedCrossRef

de Groot M, Reijneveld JC, Aronica E, Heimans JJ (2011) Epilepsy in patients with a brain tumour: focal epilepsy requires focused treatment. Brain 135:1002–1016PubMedCrossRef

de Oliveira Lima GL, Duffau H (2015) Is there a risk of seizures in “preventive” awake surgery for incidental diffuse low-grade gliomas? J Neurosurg 122:1397–1405CrossRef

De Witt Hamer PC, Gil Robles S, Zwinderman AH, Duffau H, Berger MS (2012) Impact of intraoperative stimulation brain mapping on glioma surgery outcome: a meta-analysis. J Clin Oncol 30:2559–2565PubMedCrossRef

Duffau H (2010) Awake surgery for nonlanguage mapping. Neurosurgery 66:523–529PubMedCrossRef

10.

Duffau H (2012) Awake surgery for incidental WHO grade II gliomas involving eloquent areas. Acta Neurochir 154:575–584PubMedCrossRef

11.

Duffau H (2013) In: Duffau H (ed) Diffuse low-grade gliomas in adults: natural history, interaction with the brain, and new individualized therapeutic strategies. Springer, LondonCrossRef

12.

Duffau H (2015) Stimulation mapping of white matter tracts to study brain functional connectivity. Nat Rev Neurol 11:255–265PubMedCrossRef

13.

Duffau H, Taillandier L (2015) New concepts in the management of diffuse low-grade glioma: proposal of a multistage and individualized therapeutic approach. Neuro Oncol 17:332–342PubMed

14.

Frauenfelder T, Tutic M, Weder W, Götti RP, Stahel RA, Seifert B, Opitz I (2011) Volumetry: an alternative to assess therapy response for malignant pleural mesothelioma? Eur Respir J 38:162–168PubMedCrossRef

15.

Gerin C, Pallud J, Deroulers C, Varlet P, Oppenheim C, Roux FX, Chrétien F, Thomas SR, Grammaticos B, Badoual M (2013) Quantitative characterization of the imaging limits of diffuse low-grade oligodendrogliomas. Neuro Oncol 15:1379–1388PubMedCentralPubMedCrossRef

16.

Haglund MM, Berger MS, Kunkel DD, Franck JE, Ghatan S, Ojemann GA (1992) Changes in gamma-aminobutyric acid and somatostatin in epileptic cortex associated with low-grade gliomas. J Neurosurg 77:209–216PubMedCrossRef

17.

Herbet G, Lanfargue G, Moritz-Gasser S, Bonnetblanc F, Duffau H (2015) Interfering with the neural activity of mirror-related frontal areas impairs mentalistic inferences. Brain Struct Funct 220:2159–2169PubMedCrossRef

18.

Ius T, Isola M, Budai R, Pauletto G, Tomasino B, Fadiga L, Skrap M (2012) Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients: clinical article. J Neurosurg 117:1039–1052PubMedCrossRef

19.

Jakola AS, Myrmel KS, Kloster R, Torp SH, Lindal S, Unsgård G, Solheim O (2012) Comparison of a strategy favoring early surgical resection vs a strategy favoring watchful waiting in low-grade gliomas. JAMA 308:1881–1888PubMedCrossRef

20.

Karnofsky DA, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, pp 191–205

21.

Kelly PJ, Daumas-Duport C, Kispert DB, Kall BA, Scheithauer BW, Illig JJ (1987) Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 66:865–874PubMedCrossRef

22.

Mandonnet E, Pallud J, Clatz O, Taillandier L, Konukoglu E, Duffau H, Capelle L (2008) Computational modeling of the WHO grade II glioma dynamics: principles and applications to management paradigm. Neurosurg Rev 31:263–269PubMedCrossRef

23.

McGirt MJ, Chaichana KL, Attenello FJ, Weingart JD, Than K, Burger PC, Olivi A, Brem H, Quinoñes-Hinojosa A (2008) Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery 63:700–707PubMedCrossRef

24.

Moritz-Gasser S, Herbet G, Duffau H (2013) Mapping the connectivity underlying multimodal (verbal and non-verbal) semantic processing: a brain electrostimulation study. Neuropsychologia 51:1814–1822PubMedCrossRef

25.

Oldfield RC (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9:97–113PubMedCrossRef

26.

Pallud J, Duffau H, Abdul Razak R, Barbarinno-Monnier P, Capelle L, Fontaine D, Frenay M, Guillet-May F, Mandonnet E, Taillandier L (2009) Influence of pregnancy in the behavior of diffuse gliomas: clinical cases of a French glioma study group. J Neurol 256:2014–2020PubMedCrossRef

27.

Pallud J, Fontaine D, Duffau H, Mandonnet E, Sanai N, Taillandier L, Peruzzi P, Guillevin R, Bauchet L, Bernier V, Baron MH, Guyotat J, Capelle L (2010) Natural history of incidental World Health Organization grade II gliomas. Ann Neurol 68:727–733PubMedCrossRef

28.

Pallud J, Mandonnet E, Deroulers C, Fontaine D, Badoual M, Capelle L, Guillet-May F, Page P, Peruzzi P, Jouanneau E, Frenay M, Cartalat-Carel S, Duffau H, Taillandier L (2010) Pregnancy increases the growth rates of World Health Organization grade II gliomas. Ann Neurol 67:398–404PubMed

29.

Pallud J, Varlet P, Devaux B, Geha S, Badoual M, Deroulers C, Page P, Dezamis E, Daumas-Duport C, Roux FX (2010) Diffuse low-grade oligodendrogliomas extend beyond MRI-defined abnormalities. Neurology 74:1724–1731PubMedCrossRef

30.

Pallud J, Andureau E, Blonski M, Sanai N, Bauchet L, Fontaine D, Mandonnet E, Dezamis E, Psimaras D, Guyotat J, Peruzzi P, Page P, Gal B, Párraga E, Baron MH, Vlaicu M, Guillevin R, Devaux B, Duffau H, Taillandier L, Capelle L, Huberfeld G (2014) Epileptic seizures in diffuse low-grade gliomas in adults. Brain 137:449–462PubMedCrossRef

31.

Potts MB, Smith JS, Molinaro AN, Berger MS (2012) Natural history and surgical management of incidentally discovered low-grade gliomas. J Neurosurg 116:365–372PubMedCrossRef

32.

Sanai N, Mirzadeh Z, Berger MS (2008) Functional outcome after language mapping for glioma resection. N Engl J Med 358:18–27PubMedCrossRef

33.

Schomas DA, Lack NN, Rao RD, Meyer FB, Shaw EG, O’Neill BP, Giannini C, Brown PD (2009) Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic. Neuro Oncol 11:437–445PubMedCentralPubMedCrossRef

34.

Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S, Tihan T, Vandenberg S, McDermott MW, Berger MS (2008) Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 26:1338–1345PubMedCrossRef

35.

Soffietti R, Baumert BG, Bello L, von Deimling A, Duffau H, Frénay M, Grisold W, Grant R, Graus F, Hoang-Xuan K, Klein M, Melin B, Rees J, Siegal T, Smits A, Stupp R, Wick W (2010) Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force. Eur J Neurol 17:1124–1133PubMedCrossRef

36.

Yordanova Y, Moritz-Gasser S, Duffau H (2011) Awake surgery for WHO grade II gliomas within “noneloquent” areas in the left dominant hemisphere: toward a “supratotal” resection. J Neurosurg 115:232–239PubMedCrossRef

Title: Long-term outcomes after supratotal resection of diffuse low-grade gliomas: a consecutive series with 11-year follow-up
Author: Hugues Duffau
Publication date: 01-01-2016
Publisher: Springer Vienna
Published in: Acta Neurochirurgica / Issue 1/2016
Print ISSN: 0001-6268
Electronic ISSN: 0942-0940
DOI: https://doi.org/10.1007/s00701-015-2621-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Long-term outcomes after supratotal resection of diffuse low-grade gliomas: a consecutive series with 11-year follow-up

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2016

Brain tumor imaging, editors; Rajan Jain, Marco Essig (2015) 384 pp, 551 illustrations, hardcover ISBN: 9781604068061 Thieme Publishers, New York/Stuttgart

Does arteriosclerosis contribute to hemifacial spasm?

Working time of neurosurgical residents in Europe—results of a multinational survey

Clinical features of clear cell meningioma: a retrospective study of 36 cases among 10,529 patients in a single institution

Parametric study of ventricular catheters for hydrocephalus

Postoperative acute cerebellar swelling after pineal surgery: pathogenesis and treatment